"I think it is long overdue that the FDA explained to us why we continue to have a problem with supply chain."
"It is time. It is past time to do something about the pharmacy benefit manager."
"This Committee is not known for its bipartisanship."
"I think that we can work together, Mr. Ranking Member, not just our Members, but our staff on trying to come up with a bipartisan solution."
"Price transparency, that is something that we should all agree on."
"I think there is a sincere desire on both sides of the aisle to do that."
"An identical prescription, a 30-day supply of imatinib would only cost $72 at Cost Plus Drugs. That is a massive difference."
"I am not defending the pharmaceutical companies, but there is a difference between the pharmaceutical companies and the PBMs."
"I am surprised and disappointed that EPA is refusing to produce Acting Administrator Goffman to appear at today's hearing."
"I think you are the right person for the job. You have taken a lot of bullets, and it is a tough job."
"We are also concerned that self-certification of income will result in fraudulent reporting."
"We have got a problem with our universities, according to multiple university presidents I have spoken with, that we have Chinese students that are stealing our intellectual property."